Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Berg

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
European Heart Journal. Acute Cardiovascular Care|December 19, 2025
Young Adults in the Cardiac Intensive Care Unit: Insights from the Critical Care Cardiology Trials Network RegistryAmeesh Isath, Tanya Sharma, Uzair Mahmood, et al.
Circulation|November 8, 2021
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF TrialDavid D Berg, Kieran F Docherty, Naveed Sattar, et al.
Journal of Cardiac Failure|August 17, 2025
Growth differentiation factor-15 and the effect of dapagliflozin in heart failure: insights from the DAPA-HF trialDavid D Berg, Kieran Docherty, Atefeh Talebi, et al.
JACC. Advances|October 3, 2025
Association Between Pressure-Adjusted Heart Rate and In-Hospital Mortality in Cardiogenic ShockCurtis R Ginder, Jacob C Jentzer, Siddharth M Patel, et al.
Journal of Cardiac Failure|January 20, 2022
Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials NetworkDavid D Berg, Carlos L Alviar, Ankeet S Bhatt, et al.
European Heart Journal. Acute Cardiovascular Care|February 8, 2022
A pragmatic lab-based tool for risk assessment in cardiac critical care: data from the Critical Care Cardiology Trials Network (CCCTN) RegistrySiddharth M Patel, Jacob C Jentzer, Carlos L Alviar, et al.
European Heart Journal|October 28, 2022
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysisEri Toda Kato, David A Morrow, Jianping Guo, et al.
European Heart Journal|August 18, 2022
A polygenic risk score predicts atrial fibrillation in cardiovascular diseaseNicholas A Marston, Amanda C Garfinkel, Frederick K Kamanu, et al.
JACC. Heart Failure|March 15, 2025
Interleukin-6 in Heart Failure With Reduced Ejection Fraction and the Effect of Dapagliflozin: An Exploratory Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure TrialKieran F Docherty, Kirsty McDowell, Paul Welsh, et al.
Journal of Intensive Medicine|September 11, 2025
Anemia as a potent marker of in-hospital mortality in patients admitted to the cardiac intensive care unit: Data from the Critical Care Cardiology Trials Network (CCCTN) RegistryChristine Chow, Rasheed Durowoju, Carlos Alviar, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
European Heart Journal. Acute Cardiovascular Care|December 19, 2025
Young Adults in the Cardiac Intensive Care Unit: Insights from the Critical Care Cardiology Trials Network RegistryAmeesh Isath, Tanya Sharma, Uzair Mahmood, et al.
Circulation|November 8, 2021
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF TrialDavid D Berg, Kieran F Docherty, Naveed Sattar, et al.
Journal of Cardiac Failure|August 17, 2025
Growth differentiation factor-15 and the effect of dapagliflozin in heart failure: insights from the DAPA-HF trialDavid D Berg, Kieran Docherty, Atefeh Talebi, et al.
JACC. Advances|October 3, 2025
Association Between Pressure-Adjusted Heart Rate and In-Hospital Mortality in Cardiogenic ShockCurtis R Ginder, Jacob C Jentzer, Siddharth M Patel, et al.
Journal of Cardiac Failure|January 20, 2022
Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials NetworkDavid D Berg, Carlos L Alviar, Ankeet S Bhatt, et al.
European Heart Journal. Acute Cardiovascular Care|February 8, 2022
A pragmatic lab-based tool for risk assessment in cardiac critical care: data from the Critical Care Cardiology Trials Network (CCCTN) RegistrySiddharth M Patel, Jacob C Jentzer, Carlos L Alviar, et al.
European Heart Journal|October 28, 2022
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysisEri Toda Kato, David A Morrow, Jianping Guo, et al.
European Heart Journal|August 18, 2022
A polygenic risk score predicts atrial fibrillation in cardiovascular diseaseNicholas A Marston, Amanda C Garfinkel, Frederick K Kamanu, et al.
JACC. Heart Failure|March 15, 2025
Interleukin-6 in Heart Failure With Reduced Ejection Fraction and the Effect of Dapagliflozin: An Exploratory Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure TrialKieran F Docherty, Kirsty McDowell, Paul Welsh, et al.
Journal of Intensive Medicine|September 11, 2025
Anemia as a potent marker of in-hospital mortality in patients admitted to the cardiac intensive care unit: Data from the Critical Care Cardiology Trials Network (CCCTN) RegistryChristine Chow, Rasheed Durowoju, Carlos Alviar, et al.
Pageof 13